March 06, 2024
ELIAS Animal Health gets USDA approval for new cancer immunotherapy
Using an individualized whole cancer cell vaccine and targeted T-cell lymphocytes, ELIAS Cancer Immunotherapy (ECI) can potentially create a “sustained immune effect” in dogs with osteosarcoma.